However, among patients with stage II disease, the differences in outcomes (DFS, OS, LRF) between risk groups did not reach statistical significance in the validation cohorts (eFigure 7 in Supplement 1 ).
← all excerpts
Deep Learning Model of Primary Tumor and Metastatic Cervical Lymph Nodes From CT for Outcome Predictions in Oropharyngeal Cancer.
1
—
—